Prognostic Factors in Patients Diagnosed with High Grade Glioma Managed with Radiotherapy: Experience at the Federico Gómez Children's Hospital of Mexico




María Fátima Chilaca-Rosas, Department of Pediatric Radiotherapy, Oncology Hospital, Centro Médico Nacional Siglo XXI and Department of Pediatric Radiotherapy, Hospital Infantil de México Federico Gómez; Mexico City, Mexico
Heynar de Jesús Pérez-Villanueva, Department of Pediatric Radiotherapy, Hospital Infantil de México Federico Gómez and Radiotherapy Department, Hospital General de México Eduardo Liceaga; Mexico City, Mexico
Noé Trinidad-Hernández, Department of Pediatric Radiotherapy, Hospital Infantil de México Federico Gómez and Department of Radiotherapy Physics, Oncology Hospital, Centro Médico Nacional Siglo XXI; Mexico City, Mexico
Juan Carlos Heredia-Gutiérrez, Radiotherapy Department, Oncology Hospital, Centro Médico Nacional Siglo XXI; Mexico City, Mexico
Héctor Urueta-Cuéllar, Department of Genetics, Hospital General de México Eduardo Liceaga; Mexico City, Mexico


Introduction: High-grade gliomas account for 15-20% of intracranial tumors in the pediatric population, usually with poor prognosis for overall survival. Objective: To identify prognostic factors for overall survival and local control in patients diagnosed with intracranial high-grade gliomas managed with conformal radiotherapy. Patients and methodology: This retrospective study assessed all high-grade glioma-diagnosed patients treated with radiotherapy at the Federico Gómez Children’s Hospital over the period 2008-2013 by means of a review of medical records, imaging files, and treatment plans. Results: The analyzed patients (n = 18) had a median age of five years. The most common localization was infratentorial. Histologies found were glioblastoma multiforme and anaplastic astrocytoma. Of the analyzed patients, 44.4% received surgical management owing to the lesion localization and their performance status. All patients received radiotherapy with > 54 Gy total dose with or without chemotherapy. Local control rate was 94.4% and median overall survival was 13 months. With regard to surgical management for gross tumor resection, subtotal tumor resection, and no resection, five-year overall survival was 100, 50, and 36%, respectively (p = 0.04). The patients showed overall survival improvement with radiotherapy total dose > 54 Gy and standard fractioning. Conclusion: In the present study, surgical gross resection and management with standard external beam radiotherapy at doses > 54 Gy were found to be predictive factors for overall survival in pediatric patients diagnosed with intracranial high-grade gliomas.



Keywords: High-grade glioma. Surgical resection. Conformal radiotherapy. Pediatrics.





ESP / ENG